Hospital
Sichuan Provincial People's Hospital四川省人民医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A+++ General list, 2023
-
Published research 18 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 10 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A+++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 四川省人民医院
- English name
- Sichuan Provincial People's Hospital
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
- SAMS&SPPH
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Dual-Energy CT-Derived Extracellular Volume Fraction for Prediction of Recurrence in Rectal Cancer: A Bicenter Study. Academic radiology, 2026
- CT-derived extracellular volume fraction and AI-assisted body composition for predicting neoadjuvant therapy response and prognosis in colorectal cancer. Abdominal radiology (New York), 2026
2 more published studies
PubMed indexes 4 papers on this condition that name this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Breast cancer
Published research
- Biomaterial-based mitochondria-targeted nanomedicine for remodeling the breast cancer tumor microenvironment and overcoming therapy resistance. Critical reviews in oncology/hematology, 2026
- An endoplasmic reticulum-enriched nanogel couples ferroptotic tumor damage with macrophage reprogramming for triple-negative breast cancer immunotherapy. Bioactive materials, 2027
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Lung cancer
Published research
- Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non-small-cell lung cancer: a randomized, multicenter, phase II trial. Cancer biology & medicine, 2026
- Pragmatic Screening for Sarcopenia in Non-Small Cell Lung Cancer: Development and Internal Validation of a Prospective Risk Model Integrating T12 CT Indices and Routine Clinical Variables. Cancer medicine, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Liver cancer
Published research
- Mint3 suppresses cuproptosis by modulating the AHR signalling pathway to facilitate the progression of hepatocellular carcinoma. Science China. Life sciences, 2026
- Magnetoreceptor Promotes Hepatocellular Carcinoma Development and Blunts Sorafenib-Induced Ferroptosis by Regulating Iron Homeostasis. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
2 more published studies
PubMed indexes 4 papers on this condition that name this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Stomach cancer
Published research
- Cancer-associated fibroblast-enriched TAGLN orchestrates HGF/c-MET-dependent transcriptional reprogramming in gastric cancer. Cancer letters, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Prostate cancer
Published research
- Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases. The aging male : the official journal of the International Society for the Study of the Aging Male, 2026
- Interpretable machine learning for individualized survival prediction in node-positive, non-metastatic prostate cancer: a population-based study. The aging male : the official journal of the International Society for the Study of the Aging Male, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Nasopharyngeal carcinoma
Published research
- Targeting FDX1 with oridonin triggers cuproptosis and inhibits tumor progression in nasopharyngeal carcinoma. The international journal of biochemistry & cell biology, 2026
- Application of delta radiomics based on cone-beam computed tomography in predicting radiotherapy efficacy for nasopharyngeal carcinoma. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Ophthalmology nominated in the Fudan list.
-
Senile cataract
Fudan specialty reputation ranking 2023
- Ophthalmology nominated https://rank.cn-healthcare.com/fudan/specialty-reputation/year/2023/sid/4
Other hospitals in Chengdu
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24